Trials / NCT05413148
The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa
Status unknown Phase 2 / Phase 3 Cell therapy
- Sponsor
- TC Erciyes University
- Treatment
- Subtenon injection of Wharton jelly derived mesenchymal stem cells; Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes; Placebo
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 70 Years
- Enrollment
- 135 participants
- Started
- 2022-08-05
- Main results expected
- 2023-07-01
- Results posted
- Not yet
- Record last updated
- 2022-09-07
What the study is testing
This clinical trial aims to study the efficacy of umbilical cord-derived mesenchymal stem cells and their exosomes in the treatment of retinitis pigmentosa. The participants will be randomized into 3 groups. Functional and structural parameters will be compared before and after the injections and also will be compared among the groups to reveal whether stem cell and their exosomes are more effective than placebo.
Where it runs
Turkey (Türkiye) (1)
- Erciyes University, Faculty of Medicine, Kayseri (recruiting now)